Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury

Neeta Adhikari, Nathan Charles, Ute Lehmann, Jennifer L. Hall

Research output: Contribution to journalReview article

57 Scopus citations

Abstract

Our understanding of the molecular signaling pathways regulating the initiation and progression of atherosclerosis or remodeling in response to injury has begun to cross the boundaries from regulation of well-described canonical pathways to the interplay between these pathways. The focus of this review is to summarize our current understanding of a finite group of transcription factors and kinases involved in vascular injury and atherosclerosis, including nuclear factor-κB (NF-κB), early growth response factor-1 (Egr-1), activator protein-1 (AP-1), hypoxia inducible factor-1α (HIF-1α), homeobox, and T cell factor/lymphoid enhancer factor (Tcf-Lef), as well as the kinases janus kinase/signal transducers and activators of transcription (JAK/ STAT), protein kinase C (PKC), p38, Rho, ERK5, JNK, p44/p42, and phosphoinositide 3 (PI3) kinase/AKT.

Original languageEnglish (US)
Pages (from-to)252-260
Number of pages9
JournalCurrent atherosclerosis reports
Volume8
Issue number3
DOIs
StatePublished - May 1 2006

Fingerprint Dive into the research topics of 'Transcription factor and kinase-mediated signaling in atherosclerosis and vascular injury'. Together they form a unique fingerprint.

  • Cite this